• Prime Editing Clears IP Fight, Sets Q3 Filing for First Liver-Targeted AATD Drug Tech Times Thu, 09 Jul 2026 18:28:36 GMT
• Prime Medicine wins arbitration to advance gene editing program, shares jump over 15%. Pluang Thu, 09 Jul 2026 14:51:16 GMT
• Prime Medicine Beats Beam Therapeutics In Patent Dispute - But Both Are Investable (PRME) Seeking Alpha Thu, 09 Jul 2026 14:22:58 GMT
• Gene editors, including powerhouse Beam Therapeutics, diverge on legal battle MSN Thu, 09 Jul 2026 02:30:27 GMT
• Gene Editors, Including Powerhouse Beam Therapeutics, Diverge On Legal Battle Investor's Business Daily Wed, 08 Jul 2026 20:09:00 GMT
• Prime Medicine Receives Favorable Ruling in Beam Therapeutics License Arbitration; Shares Rise marketscreener.com Wed, 08 Jul 2026 18:09:15 GMT
• Prime Medicine wins spat with Beam Therapeutics over AATD candidate Endpoints News Wed, 08 Jul 2026 17:52:00 GMT
• TD Cowen reiterates Buy on Prime Medicine stock after arbitration win Investing.com Wed, 08 Jul 2026 17:39:49 GMT
• Prime Medicine Secures Favorable Arbitration Ruling in Beam Therapeutics Case Benzinga Wed, 08 Jul 2026 17:29:41 GMT
• Prime Medicine wins binding arbitration against Beam Therapeutics grafa.com Wed, 08 Jul 2026 16:26:00 GMT
• Prime Medicine Shares Rise on Positive Arbitration Ruling in Beam Dispute Moomoo Wed, 08 Jul 2026 15:52:43 GMT
• Prime Medicine stock surges after winning arbitration with Beam By Investing.com Investing.com Canada Wed, 08 Jul 2026 15:14:31 GMT
• Prime wins patent fight with Beam to continue work on AATD gene editing therapy Fierce Biotech Wed, 08 Jul 2026 15:07:01 GMT
• Why is Prime Medicine stock surging today? By Investing.com Investing.com Canada Wed, 08 Jul 2026 14:56:52 GMT
• Prime Medicine Stock Pops As ARK, Analysts Back Gene Editor StocksToTrade Wed, 08 Jul 2026 14:03:00 GMT
• Prime Medicine claims victory in dispute over gene-editing technology with Beam Therapeutics STAT Wed, 08 Jul 2026 13:56:26 GMT
• Prime Medicine gains after winning arbitration with Beam Therapeutics Seeking Alpha Wed, 08 Jul 2026 13:05:44 GMT
• Prime Medicine wins arbitration over AATD therapy PM647 Investing.com Wed, 08 Jul 2026 12:34:20 GMT
• Prime Medicine wins arbitration, clears path to develop gene therapy PM647 for AATD with clinical trials in 2026. Pluang Wed, 08 Jul 2026 12:24:08 GMT
• Prime Medicine wins arbitration ruling, PM647 found within its field; Beam's claims denied TradingView Wed, 08 Jul 2026 12:03:01 GMT
• Prime Medicine (NASDAQ: PRME) cleared of breach in Beam arbitration ruling Stock Titan Wed, 08 Jul 2026 12:02:31 GMT
• Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics GlobeNewswire Wed, 08 Jul 2026 12:00:00 GMT
• Prime Medicine clears Beam dispute, keeps PM647 for AATD Stock Titan Wed, 08 Jul 2026 12:00:00 GMT
• Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal Yahoo Finance Wed, 08 Jul 2026 09:07:00 GMT
• Here’s Why H.C. Wainwright Upgraded Prime Medicine (PRME) To “Buy” Yahoo Finance Sun, 05 Jul 2026 22:07:53 GMT
• Enterprise value to revenue forward of Prime Medicine, Inc. – NASDAQ:PRME TradingView Tue, 30 Jun 2026 04:26:07 GMT
• PRME Q1 2026 Earnings: EPS Misses Estimates but Stock Gains on Pipeline Progress - Earnings Decline Risk dars.gov.et Mon, 29 Jun 2026 23:34:12 GMT
• Enterprise value to EBIT forward of Prime Medicine, Inc. – NASDAQ:PRME TradingView Mon, 29 Jun 2026 22:59:45 GMT
• Prime Medicine, Inc.(NasdaqGM: PRME) added to Russell 2500 Growth Benchmark marketscreener.com Mon, 29 Jun 2026 19:58:33 GMT
• Price to book forward of Prime Medicine, Inc. – NASDAQ:PRME TradingView Mon, 29 Jun 2026 19:48:39 GMT
• Price to sales forward of Prime Medicine, Inc. – NASDAQ:PRME TradingView Mon, 29 Jun 2026 19:32:09 GMT
• H.C. Wainwright upgrades Prime Medicine stock rating to buy By Investing.com Investing.com Nigeria Mon, 29 Jun 2026 12:38:41 GMT
• Prime Medicine, Inc.(NasdaqGM:PRME) added to Russell Microcap Growth Benchmark Index marketscreener.com Mon, 29 Jun 2026 12:33:52 GMT
• This Caseys Analyst Turns Bullish; Here Are Top 3 Upgrades For Monday Sahm Mon, 29 Jun 2026 07:00:00 GMT
• prme q1 2026 earnings: wider than expected loss amidst continued pipeline progress - next quarter guidance dars.gov.et Sun, 28 Jun 2026 18:32:37 GMT
• Prime Medicine, Inc.(NasdaqGM: PRME) added to Russell 3000 Growth Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• Prime Medicine, Inc.(NasdaqGM:PRME) added to Russell Small Cap Comp Growth Benchmark marketscreener.com Sun, 28 Jun 2026 07:00:00 GMT
• prme q1 2026 earnings: wider-than-expected loss as pre-revenue biotech advances gene editing pipeline dars.gov.et Fri, 26 Jun 2026 14:48:37 GMT
• prime medicine inc (prme) financial health: profitability & balance sheet analysis TradingKey Thu, 25 Jun 2026 09:57:13 GMT
• prime medicine (prme) short interest & short float | updated jun 2026 MarketBeat Thu, 25 Jun 2026 07:00:00 GMT
• lifesci capital maintains prime medicine(prme.us) with buy rating, maintains target price $6 Moomoo Tue, 23 Jun 2026 10:31:00 GMT
• Prime Medicine Receives U.S. FDA Regenerative Medicine GlobeNewswire Mon, 22 Jun 2026 07:00:00 GMT
• Citizens reiterates Prime Medicine stock rating on gene therapy focus Investing.com Mon, 22 Jun 2026 07:00:00 GMT
• Prime Medicine’s CGD therapy gets FDA RMAT, speeding review Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• Prime Medicine Says PM359 Granted US FDA Regenerative Medicine Advanced Therapy Designation Moomoo Mon, 22 Jun 2026 07:00:00 GMT
• ocular therapeutix vs. prime medicine: which healthcare stock is a better buy in 2026? AOL.com Sun, 21 Jun 2026 17:43:58 GMT
• PRME Q1 2026 Earnings: Wider-Than-Expected Loss Highlights Ongoing Pre-Revenue Investment Phase - Earnings Miss Streak dars.gov.et Sun, 21 Jun 2026 07:00:00 GMT
• prime medicine, inc. (prme) reports q1 loss, misses revenue estimates MSN Fri, 19 Jun 2026 20:04:19 GMT
• analysts are bullish on these healthcare stocks: prime medicine, inc. (prme), ocular therapeutix (ocul) The Globe and Mail Fri, 19 Jun 2026 19:54:00 GMT
• prime medicine’s pm-577a cleared for clinic for wilson’s disease BioWorld News Fri, 19 Jun 2026 13:00:00 GMT
• prime medicine receives clearance for first in vivo gene therapy trial Investing.com Canada Fri, 19 Jun 2026 06:44:06 GMT
• lifesci capital maintains prime medicine(prme.us) with buy rating, maintains target price $6 富途牛牛 Thu, 18 Jun 2026 20:31:00 GMT
• Prime Medicine Announces New Zealand Clearance of Clinical GlobeNewswire Thu, 18 Jun 2026 07:00:00 GMT
• Is Prime Medicine (NASDAQ:PRME) In A Good Position To Invest In Growth? simplywall.st Thu, 18 Jun 2026 07:00:00 GMT
• Prime Medicine receives clearance for first in vivo gene therapy trial Investing.com Thu, 18 Jun 2026 07:00:00 GMT
• Prime Medicine clears first in vivo gene-editing trial for Wilson disease Stock Titan Thu, 18 Jun 2026 07:00:00 GMT
• Prime Medicine (PRME) Edges Higher as Biotech Sentiment Stabilizes Near Support - WMA Signal dars.gov.et Thu, 18 Jun 2026 07:00:00 GMT
• prime medicine inc (prme) technical analysis: support, resistance, indicators & moving averages TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• prime medicine inc (prme) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• prime medicine inc (prme) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 07:00:00 GMT
• ocular therapeutix vs. prime medicine: which healthcare stock is a better buy in 2026? AOL.com Thu, 18 Jun 2026 02:55:50 GMT
• prime medicine inc (prme) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 10:33:27 GMT
• prime medicine inc (prme) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 07:36:35 GMT
• prime medicine inc (prme) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:28:28 GMT
• prime medicine inc (prme) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 07:23:51 GMT
• prime medicine inc (prme) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 06:56:32 GMT
• prime medicine inc (prme) shareholder structure: major shareholders & institutional holdings TradingKey Tue, 16 Jun 2026 23:54:38 GMT
• prime medicine inc (prme) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Tue, 16 Jun 2026 23:53:32 GMT
• ocular therapeutix vs. prime medicine: which healthcare stock is a better buy in 2026? AOL.com Tue, 16 Jun 2026 00:42:07 GMT
• Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026? The Motley Fool Mon, 15 Jun 2026 07:00:00 GMT
• Ocular Therapeutix vs. Prime Medicine: A 2026 Analysis of Medical Innovation Stocks - News and Statistics IndexBox Mon, 15 Jun 2026 07:00:00 GMT
• Prime Medicine's Prime Editing Is Worth The Risk (NASDAQ:PRME) Seeking Alpha Sat, 13 Jun 2026 07:00:00 GMT
• prime drink group announces private placement up to c$2.2m Investing.com UK Fri, 12 Jun 2026 23:46:00 GMT
• prime medicine (prme) holds steady near support as gene editing stock seeks direction - blue chip entry points newsline.com Fri, 12 Jun 2026 15:44:41 GMT
• transcript : prime medicine, inc. presents at goldman sachs 47th annual global healthcare conference 2026, jun-10-2026 10 marketscreener.com Wed, 10 Jun 2026 19:05:38 GMT
• prime medicine stockholders reaffirm board and auditor choices The Globe and Mail Tue, 09 Jun 2026 07:00:00 GMT
• prime medicine stockholders reaffirm board and auditor choices TipRanks Mon, 08 Jun 2026 20:43:13 GMT
• prime medicine (prme) director receives 75,000 stock options at $3.06 Stock Titan Mon, 08 Jun 2026 20:14:50 GMT
• Prime Medicine (PRME) director receives 75,000 options at $3.06 Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• Prime Medicine (PRME) director receives 75,000-share stock option grant Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• Prime Medicine (PRME) director and 10% owner receives 75,000-share option grant Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• Prime Medicine (PRME) awards director 75,000 stock options at $3.06 Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• prime medicine (prme) awards director david schenkein 75,000 stock options Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• prime medicine | 4: statement of changes in beneficial ownership of securities-director foster-cheek kaye i Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• is prime medicine (nasdaq:prme) in a good position to deliver on growth plans? Moomoo Mon, 08 Jun 2026 07:00:00 GMT
• prime medicine (prme) shareholders elect class i directors and ratify pwc as 2026 auditor Stock Titan Mon, 08 Jun 2026 07:00:00 GMT
• prme: directors and auditor were approved by stockholder vote, with results to be filed with the sec TradingView Fri, 05 Jun 2026 18:58:11 GMT
• prme: directors and audit firm were approved with no stockholder questions or opposition TradingView Fri, 05 Jun 2026 07:00:00 GMT
• We're Keeping An Eye On Prime Medicine's (NASDAQ:PRME) Cash Burn Rate Yahoo Finance Thu, 04 Jun 2026 07:00:00 GMT
• prime medicine ceo to speak at goldman sachs healthcare conference on june 10, 2026 Pluang Wed, 03 Jun 2026 13:49:37 GMT
• Prime Medicine Hopes FDA Will Consider 'Novel' Approval Path for First Candidate Precision Medicine Online Wed, 03 Jun 2026 07:00:00 GMT
• Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference GlobeNewswire Wed, 03 Jun 2026 07:00:00 GMT
• prime medicine ceo on one-time genetic therapies at jefferies event Stock Titan Thu, 28 May 2026 12:00:00 GMT
• Prime Medicine to Present at Jefferies Global Healthcare Conference GlobeNewswire Thu, 28 May 2026 07:00:00 GMT
• prime medicine ceo to speak at jefferies healthcare conference on june 4, 2026 Pluang Thu, 28 May 2026 07:00:00 GMT
• prme stock price, quote & chart | prime medicine inc (nasdaq:prme) ChartMill Thu, 28 May 2026 07:00:00 GMT
• stockwatch: after 1- and 6-month gains, gene editing companies await q3 results: Sage Journals Thu, 14 May 2026 18:46:17 GMT
• oppenheimer maintains prime medicine(prme.us) with buy rating, announces target price $11 Moomoo Tue, 12 May 2026 07:00:00 GMT
• chardan capital maintains prime medicine(prme.us) with buy rating, maintains target price $9 富途牛牛 Mon, 11 May 2026 11:07:48 GMT
• number of shareholders of prime medicine, inc. – nasdaq:prme TradingView Mon, 11 May 2026 09:40:30 GMT
• prime medicine, inc. (prme) reports q1 loss, misses revenue estimates MSN Mon, 11 May 2026 05:45:37 GMT
• lifesci capital maintains prime medicine(prme.us) with buy rating, maintains target price $6 Moomoo Sat, 09 May 2026 07:00:00 GMT
• prime medicine, inc. (prme) reports q1 loss, misses revenue estimates MSN Sat, 09 May 2026 06:11:18 GMT
• jonestrading initiates prime medicine(prme.us) with buy rating, announces target price $5 Moomoo Fri, 08 May 2026 19:32:00 GMT
• h.c. wainwright maintains prime medicine(prme.us) with hold rating Moomoo Fri, 08 May 2026 11:36:00 GMT
• prime medicine inc reports results for the quarter ended march 31 - earnings summary TradingView Thu, 07 May 2026 13:42:30 GMT
• prime medicine (nasdaq:prme) q1 results show revenue miss and narrower loss as key pipeline milestones loom ChartMill Thu, 07 May 2026 13:22:07 GMT
• Prime Medicine Reports First Quarter 2026 Financial Results and Provides Business Updates GlobeNewswire Thu, 07 May 2026 07:00:00 GMT
• PRIME MEDICINE ($PRME) Releases Q1 2026 Earnings Quiver Quantitative Thu, 07 May 2026 07:00:00 GMT
• Prime Medicine targets 2 liver disease filings in 2026, data due 2027 Stock Titan Thu, 07 May 2026 07:00:00 GMT
• Prime Medicine, Inc. 1Q 2026: Revenue $17.41M, EPS ($0.28) — 10-Q Summary TradingView Thu, 07 May 2026 07:00:00 GMT
• prime medicine, inc. (prme) reports q1 loss, misses revenue estimates Yahoo Finance Thu, 07 May 2026 07:00:00 GMT
• prime medicine ($prme) releases q1 2026 earnings | prme stock news Quiver Quantitative Thu, 07 May 2026 07:00:00 GMT
• prime medicine | 8-k: prime medicine reports first quarter 2026 financial results and provides business updates Moomoo Thu, 07 May 2026 07:00:00 GMT
• prime medicine (nasdaq: prme) q1 2026 results, cash runway into 2027 and pipeline update Stock Titan Thu, 07 May 2026 07:00:00 GMT
• prime medicine (nasdaq:prme) upgraded to sell at wall street zen MarketBeat Tue, 05 May 2026 07:00:00 GMT
• prme stock price, quote & chart | prime medicine inc (nasdaq:prme) ChartMill Tue, 28 Apr 2026 07:00:00 GMT
• prime medicine, inc. (prme) reports q2 loss, lags revenue estimates MSN Mon, 27 Apr 2026 22:16:35 GMT
• intellia crispr drug succeeds in late-stage study against rare swelling disorder BioPharma Dive Mon, 27 Apr 2026 07:00:00 GMT
• prime medicine (nasdaq:prme) stock rating lowered by wall street zen MarketBeat Mon, 27 Apr 2026 07:00:00 GMT
• prime medicine, inc. (prme) reports q3 loss, lags revenue estimates MSN Mon, 27 Apr 2026 04:00:46 GMT
• prime medicine, inc. (prme) reports q2 loss, lags revenue estimates MSN Sun, 26 Apr 2026 17:35:18 GMT
• prime medicine, inc. (nasdaq:prme) given average rating of "moderate buy" by brokerages MarketBeat Sat, 25 Apr 2026 07:00:00 GMT
• prime medicine, inc. (prme) reports q2 loss, lags revenue estimates MSN Sat, 25 Apr 2026 03:45:44 GMT
• prme price today: prime medicine, inc. stock price, quote & chart | mexc MEXC Exchange Fri, 24 Apr 2026 07:00:00 GMT
• prme (prime medicine inc.) posts 55 percent year over year q4 2025 revenue growth, shares rise modestly. Xã Thanh Hà Thu, 23 Apr 2026 12:28:51 GMT
Prime Medicine, Inc.(NASDAQ:PRME) 
Prime Medicine, Inc., a biotechnology company, delivers genetic therapies to address diseases by deploying gene editing technology. It offers Prime Editors with a Prime Editor protein, comprising a fusion between a Cas protein and a reverse transcriptase enzyme; and a pegRNA, which targets the Prime...
Website: https://www.primemedicine.com
Founded: 2019
IPO Price: $17 (Oct 20, 2022)
Full Time Employees: 150
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends